First treatment for serious chronic lung disease
Submitted by Anonymous (not verified) on 17 October 2025 - 11:05
First treatment for serious chronic lung disease
Opinion/decision on a Paediatric investigation plan (PIP): Rezzayo, rezafungin acetate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0343/2024
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Opinion/decision on a Paediatric investigation plan (PIP): Rezzayo, rezafungin acetate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0343/2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 October 2025
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 October 2025
Summary of opinion: Libtayo, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Libtayo, 16/10/2025 Positive
Summary of opinion: Breyanzi, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Breyanzi, 16/10/2025 Positive
Summary of opinion: Gazyvaro, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Gazyvaro, 16/10/2025 Positive
Summary of opinion: Cejemly, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Cejemly, 16/10/2025 Positive
Summary of opinion: Pyrukynd, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Pyrukynd, 16/10/2025 Positive
EMA confirms suspension of sickle cell disease medicine Oxbryta
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
EMA confirms suspension of sickle cell disease medicine Oxbryta
Summary of opinion: Tremfya, 16/10/2025 Positive
Submitted by Anonymous (not verified) on 17 October 2025 - 11:00
Summary of opinion: Tremfya, 16/10/2025 Positive